Arizona State Retirement System’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,386
Closed -$83.3K 2060
2025
Q4
$83.3K Sell
23,386
-1,850
-7% -$11.3K ﹤0.01% 2035
2025
Q3
$225K Buy
25,236
+411
+2% +$4.17K ﹤0.01% 1909
2025
Q2
$229K Buy
24,825
+528
+2% +$4.51K ﹤0.01% 1855
2025
Q1
$208K Buy
+24,297
New +$229K ﹤0.01% 1871
2024
Q2
Sell
-22,559
Closed -$115K 2111
2024
Q1
$115K Sell
22,559
-350
-2% -$1.97K ﹤0.01% 2061
2023
Q4
$213K Sell
22,909
-108
-0.5% -$744 ﹤0.01% 1916
2023
Q3
$151K Buy
23,017
+657
+3% +$5.23K ﹤0.01% 1987
2023
Q2
$182K Sell
22,360
-229
-1% -$1.96K ﹤0.01% 1989
2023
Q1
$194K Buy
22,589
+596
+3% +$5.95K ﹤0.01% 1950
2022
Q4
$204K Buy
21,993
+957
+5% +$10.2K ﹤0.01% 1900
2022
Q3
$217K Buy
21,036
+393
+2% +$4.15K ﹤0.01% 1835
2022
Q2
$207K Buy
20,643
+1,122
+6% +$10.6K ﹤0.01% 1917
2022
Q1
$240K Buy
19,521
+163
+0.8% +$2K ﹤0.01% 1926
2021
Q4
$336K Buy
19,358
+1,234
+7% +$23.4K ﹤0.01% 1767
2021
Q3
$325K Buy
18,124
+40
+0.2% +$796 ﹤0.01% 1788
2021
Q2
$413K Buy
+18,084
New +$268K ﹤0.01% 1688

Other funds holding AVXL

Arizona State Retirement System's AVXL Position: Q1 2026 in Review

Arizona State Retirement System sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 23,386 shares — an estimated $83.3K sold.

Arizona State Retirement System first reported a position in AVXL in Q2 2021 and held it in 16 quarters. The position peaked at $413K in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Arizona State Retirement System reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Arizona State Retirement System sold 23,386 Anavex Life Sciences shares in Q1 2026, an estimated $83.3K.
  • Arizona State Retirement System first reported a position in Anavex Life Sciences in Q2 2021 and held it in 16 quarters.
  • Arizona State Retirement System's Anavex Life Sciences position peaked at $413K in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.